Results 11 to 20 of about 276,679 (267)

Lineage tracing of Pf4-Cre marks hematopoietic stem cells and their progeny [PDF]

, 2012
The development of a megakaryocyte lineage specific Cre deleter, using the Pf4 (CXCL4) promoter (Pf4-Cre), was a significant step forward in the specific analysis of platelet and megakaryocyte cell biology.
Calaminus, Simon, Watson, Steve P., Tessa L. Holyoake, Guitart, Amelie V., Amelie V Guitart, Calaminus, Simon D J, Machesky, Laura, Schachtner, Hannah, Steve P Watson, Amelie V. Guitart, Amy Sinclair, Amelie Guitart, Kranc, Kamil R., Machesky, Laura M, Holyoake, Tessa L., Holyoake, Tessa L, Calaminus, Simon D.J., Steve P. Watson, Watson, Steve P, Guitart, Amelie, Machesky, Laura M., Simon D J Calaminus, Kranc, Kamil R, Watson, Steve, Laura M. Machesky, Holyoake, Tessa, Sinclair, Amy, Hannah Schachtner, Simon D. J. Calaminus, Laura M Machesky, Guitart, Amelie, V, Tessa L Holyoake, Kranc, Kamil, Kamil R. Kranc, Kamil R Kranc   +34 more
core   +1 more source

The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia

Nature Communications, 2017
Overriding cytarabine resistance in AML remains an unmet medical need. Here, the authors show that the CHK1 inhibitor GDC-0575 in combination with cytarabine and G-CSF has a significant anti-leukemic effect without toxicity to normal marrow stem and ...
Alessandro Di Tullio, Kevin Rouault-Pierre, Ander Abarrategi, Syed Mian, William Grey, John Gribben, Aengus Stewart, Elizabeth Blackwood, Dominique Bonnet   +8 more
doaj   +1 more source

Expression quantitative trait loci are highly sensitive to cellular differentiation state [PDF]

, 2009
Blood cell development from multipotent hematopoietic stem cells to specialized blood cells is accompanied by drastic changes in gene expression for which the triggers remain mostly unknown.
Gerrits, Alice,, Xusheng Wang, Wang, Xusheng,, Breitling, Rainer, Breitling, R., Breitling, Rainer,, Gerald de Haan, Leonid V. Bystrykh, Li, Y., Dontje, B., Dontje, Bert,, Tesson, Bruno M.,, Weersing, Ellen,, Haan, Gerald de,, Bystrykh, L.V., Wang, Xusheng, Ellen Weersing, Ausema, Albertina, De Haan, Gerald, Alice Gerrits, Bert Dontje, de Haan, G., Li, Yang,, Wang, X., Gerrits, A., Bruno M Tesson, Leonid V Bystrykh, Bystrykh, Leonid V.,, Jansen, Ritsert C.,, Gerrits, Alice, Bruno M. Tesson, Jansen, Ritsert C., Rainer Breitling, Dethmers-Ausema, B, Ritsert C Jansen, Ausema, Albertina,, Albertina Ausema, Jansen, R.C., Dontje, Bert, Yang Li, Ritsert C. Jansen, Tesson, B.M., Bystrykh, Leonid V., Weersing, Ellen, de Haan, Gerald; id_orcid, Li, Yang, Tesson, Bruno M.   +46 more
core   +1 more source

Isoform-specific potentiation of stem and progenitor cell engraftment by AML1/RUNX1 [PDF]

, 2007
Background: AML1/RUNX1 is the most frequently mutated gene in leukaemia and is central to the normal biology of hematopoietic stem and progenitor cells. However, the role of different AML1 isoforms within these primitive compartments is unclear.
Hong, DL, Shinobu Tsuzuki, Tsuzuki, S, Dengli Hong, Enver Tariq, Tsuzuki Shinobu, Matsuo Keitaro, Keitaro Matsuo, Tariq Enver, Hong Dengli, Seto Masao, Rajeev Gupta, Matsuo, K, Gupta Rajeev, Gupta, R, Seto, M, Hong, D, Enver, T, Masao Seto   +18 more
core   +1 more source

A dual origin for Bcr-Abl gene translocation/fusion as dynamics of synergism of the hematopoietic stem cell and hemangioblast in chronic myeloid leukemia [PDF]

, 2015
Contextual BCR-ABL tyrosine kinase over-activity determines in formulated fashion the emergence of proliferation and anti-apoptosis that arise largely as derived phenomena of otherwise homeostatic mechanisms of the c-ABL gene within hematopoietic ...
Agius, Lawrence M.
core   +1 more source

The Myc/Max/Mxd Network Is a Target of Mutated Flt3 Signaling in Hematopoietic Stem Cells in Flt3-ITD-Induced Myeloproliferative Disease

Stem Cells International, 2018
Acute myeloid leukemia (AML) has poor prognosis due to various mutations, e.g., in the FLT3 gene. Therefore, it is important to identify pathways regulated by the activated Flt3 receptor for the discovery of new therapeutic targets.
Farhan Basit, Maria Andersson, Anne Hultquist   +2 more
doaj   +1 more source

Generation and characterization of erythroid cells from human embryonic stem cells and induced pluripotent stem cells : an overview [PDF]

, 2011
Because of the imbalance in the supply and demand of red blood cells (RBCs), especially for alloimmunized patients or patients with rare blood phenotypes, extensive research has been done to generate therapeutic quantities of mature RBCs from ...
Bönig, Halvard-Björn, Chang, Kai-Hsin, Kai-Hsin Chang, Thalia Papayannopoulou, Halvard Bonig, Papayannopoulou, Thalia   +5 more
core   +1 more source

The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia

Journal of Hematology & Oncology, 2017
Background The optimal monitoring schedules and cutoff minimal residual disease (MRD) levels for the accurate prediction of relapse at all time points after allogeneic hematopoietic stem cell transplantation (allo-HSCT) remain unclear in patients with t ...
Ya-Zhen Qin, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Huan Chen, Wei Han, Yu-Hong Chen, Feng-Rong Wang, Jing-Zhi Wang, Yao Chen, Xiao-Dong Mo, Xiao-Su Zhao, Ying-Jun Chang, Kai-Yan Liu, Xiao-Jun Huang   +14 more
doaj   +1 more source

Notch promotes neural lineage entry by pluripotent embryonic stem cells [PDF]

, 2006
A central challenge in embryonic stem (ES) cell biology is to understand how to impose direction on primary lineage commitment. In basal culture conditions, the majority of ES cells convert asynchronously into neural cells.
Smith, Austin G, Austin G Smith, Heavey Barry, Alexandra Benchoua, Benchoua, Alexandra, Smith, Austin,, Benchoua Alexandra, Sally Lowell, Smith Austin G, Lowell, Sally; id_orcid, Smith, Austin, G., Lowell Sally, Lowell, Sally, Heavey, Barry, Barry Heavey   +14 more
core   +1 more source

Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis

Experimental Hematology & Oncology, 2017
Background Ruxolitinib is a potent inhibitor of JAK1/2 with proven efficacy in myelofibrosis. In recent years, research in graft versus host disease (GVHD) has revealed the role of activation of JAK pathways in alloreactive lymphocytes. Some reports have
Mauricio Sarmiento Maldonado, Pablo Ramírez Villanueva, Pablo Bertín Cortes-Monroy, Veronica Jara Arias, Katherine Soto Donoso, Pablo Uribe Gonzalez, Mauricio Ocqueteau Tachini, Jose Antonio Perez-Simón   +7 more
doaj   +1 more source